Cancer News and Research

Latest Cancer News and Research

Wolverine Venture Fund participates in $8M series A round of financing for Delphinus Medical Technologies

The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in an $8 million series A round of financing for Delphinus Medical Technologies, Inc.

4 Jun 2010

St. Jude receives top spot in 2010-11 Best Children's Hospital rankings

St. Jude Children's Research Hospital has been named the nation's top children's cancer hospital in the 2010-11 Best Children's Hospital rankings published in U.S. News & World Report. St. Jude received the best overall score summarizing quality of care. St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children and serves as an international resource to physicians and researchers.

4 Jun 2010

ELLICSR research centre opened at UHN

What do you get when you combine a comedian, a magician, a radio show host, and a chef? A group of cancer survivors and caregivers celebrating National Cancer Survivors Day at the opening of a unique new research centre at University Health Network (UHN), the first of its kind in Canada.

4 Jun 2010

Hiru, MindUp BioResearch comment on recent research findings in cancer treatments

Hiru Corporation and its European subsidiary MindUp BioResearch comment on the recent research findings in the field of cancer treatments for multi-drug resistant non-small cell lung cancer.

4 Jun 2010

American Cancer Society and NPCRC award $1.8M for palliative care research

The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $1.8 million in research grants to researchers at 12 institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers. The studies will be conducted over the next two years. Since 2007, a collaborative effort by the organizations has awarded 51 grants totaling almost $7 million.

4 Jun 2010

State roundup: Health law could be critical for Miss.'s poor; Colorado passes end-of-life care laws, Penn. details plan for high risk pool

The health care overhaul, which "provides hundreds of billions of dollars to help states expand medical insurance for the poor," could prove critical for Mississippi, which "has the highest poverty rate in the nation and some of the sickest people, with the country's highest rate of heart disease and the second-highest rate of diabetes.

4 Jun 2010

New UNC-Olympus Research Imaging Center opens doors

The University of North Carolina (UNC) at Chapel Hill today opened the doors of a new facility designed to be one of the world's most sophisticated research centers devoted to life science imaging. The new UNC-Olympus Research Imaging Center provides researchers with advanced microscopes and camera equipment, software, consultation and expertise, in an environment intended to encourage the highest levels of scientific inquiry.

From Evident Corporation - Life Sciences 4 Jun 2010

ASGE issues guidelines on ethnicity, gastrointestinal diseases and endoscopic procedures

The American Society for Gastrointestinal Endoscopy (ASGE) has issued guidelines addressing ethnicity, gastrointestinal diseases and endoscopic procedures. The guideline suggests that colorectal cancer screening should begin at age 45 for average risk African-American men and women, and that it is recommended that colorectal cancer screening be emphasized for other minority ethnic groups that have lower screening utilization rates.

4 Jun 2010

Report ranks best children's hospitals

U.S. News & World Report reports on the nation's best children's hospitals: "Out of all of the roughly 5,000 U.S. hospitals, only about 1 in 30 has deep expertise in caring for children with serious problems. For youngsters who need that quality of care, the Best Children's Hospitals rankings showcase the medical centers that see kids every day who have cancer, cystic fibrosis, defective hearts, and countless other life-threatening or rare conditions beyond the capabilities of most hospitals, even those with sizable pediatric departments.

4 Jun 2010

BSGI effective for evaluating unclear mammographic or ultrasound findings

Researchers at the Legacy Good Samaritan Hospital in Portland, Oregon presented data on the clinical use of Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique, at the American Society of Breast Surgeons Annual meeting in Las Vegas in April: Breast Specific Gamma Imaging Used As An Adjunct to Mammography.

4 Jun 2010

Study: 10% increase in cigarette pricing can reduce smoking among people with alcohol, drug disorders

A new study from the David Geffen School of Medicine at UCLA suggests that increasing cigarette taxes could be an effective way to reduce smoking among individuals with alcohol, drug or mental disorders.

4 Jun 2010

Detailed analysis of epigenetics of Wilms tumor reveals similarities to stem cells

A detailed analysis of the epigenetics - factors controlling when and in what tissues genes are expressed - of Wilms tumor reveals striking similarities to stem cells normally found in fetal kidneys. These findings by Massachusetts General Hospital Cancer Center researchers have revealed new cellular pathways that are critical for Wilms tumor development and may also apply to other pediatric cancers.

4 Jun 2010

CHOC Children's receives royalty-free research license to certain StemCells' patents

StemCells, Inc. and the Children's Hospital of Orange County ("CHOC Children's") announced today that they have entered into an agreement that provides CHOC Children's with a royalty-free research license to certain of StemCells' patents. This license authorizes CHOC Children's to proliferate, maintain and use human neural stem cells for non-commercial purposes.

4 Jun 2010

Royal Philips Electronics, RXi Pharmaceuticals sign joint research agreement

Royal Philips Electronics and RXi Pharmaceuticals Corporation, a US-based biopharmaceutical company, today announced that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference.

4 Jun 2010

Early detection and removal of pancreatic cysts may lower cancer risk: Researchers

Working with researchers from the University of Michigan and Indiana University, Van Andel Research Institute investigators have developed a method that could be used to predict whether pancreatic cysts are benign or are precursors to invasive cancer.

4 Jun 2010

FDA clears Abbott's new ARCHITECT HE4 assay for monitoring ovarian cancer

The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease.

4 Jun 2010

Amorfix Life Sciences signs licensing agreement with PREVENT

Amorfix Life Sciences Ltd. and Pan-Provincial Vaccine Enterprise Inc. of Saskatoon, Saskatchewan, today announced that the two groups have entered into a licensing agreement granting PREVENT exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis vaccines.

3 Jun 2010

OMHS invites community to participate in 5K Walk-Run events

Owensboro Medical Health System will officially break ground for its 447-bed replacement hospital June 5th with a 5K Walk-Run, activities for families and a ceremony that includes participation from OMHS Board of Directors, employees, physicians, several community groups and elected officials, including US Rep. Brett Guthrie.

3 Jun 2010

MicroStockProfit.com releases investment report featuring Rexahn Pharmaceuticals

MicroStockProfit.com announces an investment report featuring Rexahn Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

3 Jun 2010

Testosterone deficiency can lead to multiple disorders

Almost a quarter of men treated for cancer in their childhood suffer from a deficiency of the male sex hormone testosterone.

3 Jun 2010

Cancer News and Research

Latest Cancer News and Research

Wolverine Venture Fund participates in $8M series A round of financing for Delphinus Medical Technologies

St. Jude receives top spot in 2010-11 Best Children's Hospital rankings

ELLICSR research centre opened at UHN

Hiru, MindUp BioResearch comment on recent research findings in cancer treatments

American Cancer Society and NPCRC award $1.8M for palliative care research

State roundup: Health law could be critical for Miss.'s poor; Colorado passes end-of-life care laws, Penn. details plan for high risk pool

New UNC-Olympus Research Imaging Center opens doors

ASGE issues guidelines on ethnicity, gastrointestinal diseases and endoscopic procedures

Report ranks best children's hospitals

BSGI effective for evaluating unclear mammographic or ultrasound findings

Study: 10% increase in cigarette pricing can reduce smoking among people with alcohol, drug disorders

Detailed analysis of epigenetics of Wilms tumor reveals similarities to stem cells

CHOC Children's receives royalty-free research license to certain StemCells' patents

Royal Philips Electronics, RXi Pharmaceuticals sign joint research agreement

Early detection and removal of pancreatic cysts may lower cancer risk: Researchers

FDA clears Abbott's new ARCHITECT HE4 assay for monitoring ovarian cancer

Amorfix Life Sciences signs licensing agreement with PREVENT

OMHS invites community to participate in 5K Walk-Run events

MicroStockProfit.com releases investment report featuring Rexahn Pharmaceuticals

Testosterone deficiency can lead to multiple disorders

Understanding the DNA Damage Response in Innate Immunity eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in